GEOM THERAPEUTICS
Geom Therapeutics is a biotechnology company focused on the development of novel antibiotics for multidrug-resistant Gram-negative infections. Geom is a joint venture with LegoChem Biosciences, a publicly traded Korean biotechnology company (KOSDAQ:141080) and the inventor of GT-1. GT-1, their lead product candidate, a cephalosporin with a novel uptake mechanism, has demonstrated broad spectrum efficacy against Gram-negative pathogens. They are developing GT-1 for serious bacterial infections, ... including those caused by MDR P. aeruginosa and Acinetobacter spp. They have built an exceptional research and development team with deep expertise in the development of new antibiotics from discovery through approval. Their mission is to improve patientsโ lives by developing novel antibiotics to treat resistant infections for which there are no available therapies.
GEOM THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2015-12-22
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.geomtherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
415-533-3236
Total Funding:
4.36 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail GoDaddy DNS Google Google Cloud Google Cloud Iowa
Similar Organizations
Cygnal Therapeutics
Cygnal Therapeutics is a biotechnology company
Emendo Biotherapeutics
Emendo Biotherapeutics is a biotechnology company
GemPharmatech
GemPharmatech is a biotechnology firm.
Libra Therapeutics
Libra Therapeutics is a biotechnology company.
Neomorph
Neomorph is a biotechnology company.
Primmune Therapeutics
Primmune Therapeutics is a Biotechnology company.
Caraway Therapeutics
Rheostat Therapeutics is a bio therapeutics company.
RNADerm Therapeutics
RNADerm Therapeutics is a biotechnology company.
Saol Therapeutics
Saol Therapeutics is a biotech pharmaceutical company.
Telum Therapeutics
Telum Therapeutics is a biotechnology company.
Current Employees Featured
Founder
Official Site Inspections
http://www.geomtherapeutics.com
- Host name: lb-212-212.above.com
- IP address: 103.224.212.212
- Location: Australia
- Latitude: -33.494
- Longitude: 143.2104
- Timezone: Australia/Sydney
More informations about "Geom Therapeutics"
Geom Therapeutics - Crunchbase Company Profile & Funding
Geom Therapeutics is a biotechnology company focused on the development of novel antibiotics for multidrug-resistant Gram-negative infections. Geom is a joint venture with LegoChem โฆSee details»
Geom Therapeutics Company Profile - Office Locations ... - Craft
Geom Therapeutics is a biotechnology company that develops antibiotics for multidrug-resistant Gram-negative infections. It provides GT-1, a cephalosporin drug candidate that is used to โฆSee details»
Geom Therapeutics Company Profile | Management and โฆ
Geom Therapeutics Profile and History Geom Therapeutics is a biopharmaceutical company focused on the development of novel antibiotics for MDR gram-negative infections. Geom is a โฆSee details»
Geom Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Geom Therapeutics, Inc. of San Francisco, CA. Get the latest business insights from Dun & Bradstreet.See details»
Geom Therapeutics - Overview, News & Similar companies
Apr 1, 2019 Geom Therapeutics is a biopharmaceutical company focused on the development of novel antibiotics for MDR gram-negative infections. Geom is a joint venture with LegoChem โฆSee details»
Geom Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Geom Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 literature, Drug:LCB10-0200.See details»
Geom Therapeutics - PitchBook
Geom Therapeutics was founded in 2016. Where is Geom Therapeutics headquartered? Geom Therapeutics is headquartered in San Francisco, CA. What industry is Geom Therapeutics in? โฆSee details»
Geom Therapeutics - Products, Competitors, Financials, Employees ...
The US-based startup Geom Therapeutics , in partnership with a Korean biotechnology company LegoChem Biosciences, provides GT-1, a novel cephalosporin class antibiotic. GT-1, with the โฆSee details»
Geom Therapeutics - VentureRadar
Geom Therapeutics VentureRadar profile. Find out more about Geom Therapeutics, Small Molecule Pharmaceuticals.See details»
Geom Therapeutics, Inc. | Insights
Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Geom Therapeutics - Company Profile - Tracxn
Oct 31, 2024 Geom Therapeutics ranks 132nd among 200 active competitors. 76 of its competitors are funded while 37 have exited. Overall, Geom Therapeutics and its competitors โฆSee details»
Geom Therapeutics Announces Agreement with National Institute โฆ
SAN DIEGO, Sept. 13, 2017 /PRNewswire/ -- Geom Therapeutics, Inc., today announced a Clinical Trial Agreement (CTA) with the National Institute of Allergy and Infectious Diseases โฆSee details»
Geom Therapeutics to Develop and Commercialize LegoChem โฆ
Sep 27, 2017 Geom Therapeutics is a biotechnology company focused on the development of novel antibiotics for MDR gram-negative infections. We are a joint venture with LegoChem โฆSee details»
Geom Therapeutics To Develop And Commercialize LegoChem โฆ
Sep 27, 2017 Geom Therapeutics is a biotechnology company focused on the development of novel antibiotics for MDR gram-negative infections. We are a joint venture with LegoChem โฆSee details»
Geom Therapeutics To Present Data From Antibiotic Drug โฆ
May 30, 2018 Geom Therapeutics is a biotechnology company focused on the development of novel antibiotics for MDR gram-negative infections. Geom is a joint venture with LegoChem โฆSee details»
Geom Therapeutics Announces Agreement With NIAID For Clinical ...
SAN DIEGO, Sept. 13, 2017 /PRNewswire/ -- Geom Therapeutics, Inc., today announced a Clinical Trial Agreement (CTA) with the National Institute of Allergy and Infectious Diseases โฆSee details»
Geom Therapeutics To Present Data From Antibiotic Drug
SAN FRANCISCO, April 1, 2019 /PRNewswire/ -- Geom Therapeutics, Inc., a privately held biopharmaceutical company focused on the development of novel antibiotics for multidrug โฆSee details»
Geom Therapeutics, Inc. Expands its Partnership with LegoChem ...
Sep 27, 2017 Geom Therapeutics, Inc. announced it has expanded its partnership with LegoChem Biosciences by entering into a license agreement for access to LegoChem โฆSee details»
Geomtherapeutics Cyber Security Rating & Vendor Risk Report ...
View Geomtherapeutics's cyber security risk rating against other vendors' scores. Explore cyber risks, data breaches, and cybersecurity incidents involving Geomtherapeutics ... along with โฆSee details»